| Valacyclovir | Infectious Disease | LC/MS/MS | 1-400 ng/mL | Human EDTA Plasma |
| Valproic Acid | Central Nervous System Agents | LC/MS/MS | 0.5-100 µg/mL | Human EDTA Plasma |
| Valproic Acid | Central Nervous System Agents | LC/MS/MS | 1-100µg/mL | Human Urine |
| Valproic Acid | Central Nervous System Agents | LC/MS/MS | 1-100µg/mL | Human Serum |
| Valproic Acid Glucuronide | Central Nervous System Agents | LC/MS/MS | 1-100µg/mL | Human Urine |
| Valproic Acid Glucuronide | Central Nervous System Agents | LC/MS/MS | 1-100µg/mL | Human Serum |
| Valproic Acid Glucuronide | Central Nervous System Agents | LC/MS/MS | 1-100µg/mL | Human Serum |
| Valsartan | Cardiovascular | LC/MS/MS | 20-10000 ng/mL | Human EDTA Plasma |
| Vardenefil | Cardiovascular | LC/MS/MS | 80-40000 pg/mL | Human Plasma |
| Venlafaxine; O-desmethylvenlafaxine | Central Nervous System Agents | LC/MS/MS | 5-200 ng/ml; 5-400 ng/ml | Human EDTA Plasma |
| Venlafaxine; O-desmethylvenlafaxine | Central Nervous System Agents | LC/MS/MS | 1-150 ng/ml; 2-200 ng/ml | Human EDTA Plasma |
| Venlafaxine; O-desmethylvenlafaxine | Central Nervous System Agents | LC/MS/MS | 1-200 ng/ml; 3-300 ng/ml | Human EDTA Plasma |
| Venlafaxine; O-desmethyl-venlafaxine | Central Nervous System Agents | LC/MS/MS | 1-200 ng/mL; 3-300 ng/mL | Human EDTA Plasma |
| Verapamil; Normethylverapamil (Chiral) | Cardiovascular | LC/MS/MS | 1-100 ng/mL | Human EDTA Plasma |
| Verapamil; Norverapamil | LC/MS/MS | 1-500 ng/mL | Human Plasma | |
| Vinorelbine | Oncology | LC/MS/MS | 1-1000 ng/mL | Human EDTA Plasma |
| Voriconazole | Infectious Disease, Dermatology | LC/MS/MS | 5-2000 ng/mL | Human EDTA Plasma |